Skip to main content

Advertisement

SpringerLink
Log in

Infliximab therapy for inflammatory colitis in an infant with NEMO deficiency

  • Brief Report
  • Published:
Immunologic Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Hanson EP, et al. Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity. J Allergy Clin Immunol. 2008;122:1169–1177.e16.

    Article  CAS  Google Scholar 

  2. Aradhya S, Courtois G, Rajkovic A, Lewis RA, Levy M, Israël A, et al. Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma). Am J Hum Genet. 2001;68:765–71.

    Article  CAS  Google Scholar 

  3. Pannicke U, Baumann B, Fuchs S, Henneke P, Rensing-Ehl A, Rizzi M, et al. Deficiency of ınnate and acquired ımmunity caused by an IKBKB mutation. N Engl J Med. 2013;369:2504–14.

    Article  CAS  Google Scholar 

  4. Klemann C, Pannicke U, Morris-Rosendahl DJ, Vlantis K, Rizzi M, Uhlig H, et al. Transplantation from a symptomatic carrier sister restores host defenses but does not prevent colitis in NEMO deficiency. Clin Immunol. 2016;164:52–6.

    Article  CAS  Google Scholar 

  5. Tegtmeyer D, Seidl M, Gerner P, Baumann U, Klemann C. Inflammatory bowel disease caused by primary immunodeficiencies-clinical presentations, review of literature, and proposal of a rational diagnostic algorithm. Pediatr Allergy Immunol. 2017;28:412–29.

    Article  Google Scholar 

  6. Toussi SS, Pan N, Walters HM, Walsh TJ. Infections in children and adolescents with juvenile idiopathic arthritis and inflammatory bowel disease treated with tumor necrosis factor-α inhibitors: systematic review of the literature. Clin Infect Dis. 2013;57:1318–30.

    Article  Google Scholar 

  7. Kelsen JR, Grossman AB, Pauly-Hubbard H, Gupta K, Baldassano RN, Mamula P. Infliximab therapy in pediatric patients 7 years of age and younger. J Pediatr Gastroenterol Nutr. 2014;59:758–62.

    Article  CAS  Google Scholar 

  8. Mizukami T, Obara M, Nishikomori R, Kawai T, Tahara Y, Sameshima N, et al. Nunoi H. Successful treatment with infliximab for inflammatory colitis in a patient with X-linked anhidrotic ectodermal dysplasia with immunodeficiency. J Clin Immunol. 2012;32:39–49.

    Article  Google Scholar 

  9. Yang J, Cheuk DK, Ha SY, Chiang AK, Lee TL, Ho MH, et al. Infliximab for steroid refractory or dependent gastrointestinal acute graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation. Pediatr Transplant. 2012;16:771–8.

    Article  CAS  Google Scholar 

  10. Stray-Pedersen A, Sorte HS, Samarakoon P, Gambin T, Chinn IK, Coban Akdemir ZH, et al. Primary immunodeficiency diseases: genomic approaches delineate heterogeneous Mendelian disorders. J Allergy Clin Immunol. 2017;139:232–45.

    Article  Google Scholar 

  11. Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, Danese S, et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature. 2007;446:557–61.

    Article  CAS  Google Scholar 

  12. Fish JD, Duerst RE, Gelfand EW, Orange JS, Bunin N. Challenges in the use of allogeneic hematopoietic SCT for ectodermal dysplasia with immune deficiency. Bone Marrow Transplant. 2009;43:217–21.

    Article  CAS  Google Scholar 

  13. Miot C, Imai K, Imai C, Mancini AJ, Kucuk ZY, Kawai T, et al. Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG/NEMO mutations. Blood. 2017;130:1456–67.

    Article  CAS  Google Scholar 

  14. Nenci A, Huth M, Funteh A, Schmidt-Supprian M, Bloch W, Metzger D, et al. Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling. Hum Mol Genet. 2006;15:531–42.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

We profoundly thank Dr. Jordan Scott Orange for a great support to diagnose NEMO deficiency in the case.

Author information

Authors and Affiliations

  1. Department of Pediatric Immunology and Allergy, Selcuk University Medical Faculty, Alaeddin Keykubat Kampusu, 42130, Konya, Turkey

    Hasibe Artac, Ayca Emsen & Hulya Ucaryilmaz

  2. Department of Gastroenterology and Hepatology, Selcuk University Medical Faculty, Konya, Turkey

    Halil Haldun Emiroglu

  3. Department of Pediatric Hematology and Oncology, Medical Park Antalya Hospital, Antalya, Turkey

    Vedat Uygun

  4. Center for Human Immunobiology-Immunology-Allergy-Rhematology, Texas Children Hospital-Baylor College of Medicine, Houston, TX, USA

    Asbjørg Stray-Pedersen

Authors
  1. Hasibe Artac
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ayca Emsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hulya Ucaryilmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Halil Haldun Emiroglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vedat Uygun
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Asbjørg Stray-Pedersen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hasibe Artac.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Artac, H., Emsen, A., Ucaryilmaz, H. et al. Infliximab therapy for inflammatory colitis in an infant with NEMO deficiency. Immunol Res 67, 450–453 (2019). https://doi.org/10.1007/s12026-019-09100-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12026-019-09100-z

Search

Navigation